Macera Therapeutics

BiotechnologyAngelNanjing, China

Latest round

Angel

Last raised

Dec 2022

Total raised

Undisclosed

Investors

3

About Macera Therapeutics

, dba Macera Therapeutics, is a biotechnology company engaged in the R&D of macrophage cell immunotherapy new drugs for tumors. The company was co-founded by Pingping Shen, a Professor at the School of Life Sciences, Nanjing University and Yijun Chen who holds a PhD from the National University of Singapore School of Medicine and worked at Singapore General Hospital conducting research in tumor endocrinology. Macera Therapeutics engages in the R&D of new drugs for treating fibrotic diseases and solid tumors adopting the CAR-Macrophage technology. It also developed molecular editing and manipulation systems, IPSC-derived immune cell differentiation systems, ligand-receptor, and other information flow recognition and conduction technology platforms, which can edit the genes, identify the target antigens, and kill the tumor cells. The company generates revenue from developing macrophage immunotherapy drugs for the treatment of solid tumors and autoimmune diseases.

Who invested in Macera Therapeutics

3 investors across 1 round

See all investors in Macera Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Dec 8, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Macera Therapeutics

Who invested in Macera Therapeutics?

Macera Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Macera Therapeutics raised?

Macera Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Macera Therapeutics last raise money?

Macera Therapeutics's most recent round on record is a Angel, in Dec 2022.

What does Macera Therapeutics do?

, dba Macera Therapeutics, is a biotechnology company engaged in the R&D of macrophage cell immunotherapy new drugs for tumors.

Where is Macera Therapeutics headquartered?

Macera Therapeutics is headquartered in Nanjing, China.

Which VCs invest in companies like Macera Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Macera Therapeutics's stage. Their profiles are linked below.

Raising like Macera Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.